These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31533660)

  • 1. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
    Beeharry MK; Zhu ZL; Liu WT; Yao XX; Yan M; Zhu ZG
    BMC Cancer; 2019 Sep; 19(1):932. PubMed ID: 31533660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
    Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
    BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study.
    Yu P; Huang X; Huang L; Dai G; Xu Q; Fang J; Ye Z; Chai T; Du Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11491-11498. PubMed ID: 37392201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
    Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
    BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].
    Lin Y; Shen C; Guo XK; Li Y; Wang DD; Chen X; Wang Z; Wu K; Tao KX; Wu CQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):48-55. PubMed ID: 35067034
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
    Lee TY; Hsu CH; Fan HL; Liao GS; Chen TW; Chan DC
    Eur J Surg Oncol; 2022 Sep; 48(9):1972-1979. PubMed ID: 35508455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in prophylatic hyperthermic intraperitoneal chemotherapy for advanced gastric carcinoma].
    Chen X; Luo J; Liu H; Chen Y; Hu Y; Li T; Lin T; Zhu Y; Zhao M; Chen H; Li G; Yu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):593-599. PubMed ID: 29774943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching.
    Lv CB; Tong LY; Zeng WM; Chen QX; Fang SY; Sun YQ; Cai LS
    World J Surg Oncol; 2024 Sep; 22(1):244. PubMed ID: 39256787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of surgery combined with hyperthermic intraperitoneal chemotherapy in the treatment of advanced gastric cancer: a meta-analysis].
    Ni Z; Li C; Yan C; Liu W; Yao X; Chen M; Yan M; Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Dec; 19(12):1406-1413. PubMed ID: 28000200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: a Propensity Score-Matched Analysis.
    Liu L; Zheng L; Liu S; Zhang M; Zhang S; Jiang Z; Qin C; Wang D
    J Gastrointest Surg; 2023 Nov; 27(11):2297-2307. PubMed ID: 37715013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
    Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
    Langenbecks Arch Surg; 2021 Jun; 406(4):1071-1080. PubMed ID: 33611693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
    Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
    J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients.
    Costa WL; Coimbra FJ; Ribeiro HS; Diniz AL; de Godoy AL; Begnami M; Silva MJ; Fanelli MF; Mello CA
    World J Surg Oncol; 2012 Sep; 10():195. PubMed ID: 22992263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer.
    Liu L; Sun L; Zhang N; Liao CG; Su H; Min J; Song Y; Yang X; Huang X; Chen D; Chen Y; Zhang HW; Zhang H
    Int J Hyperthermia; 2022; 39(1):239-245. PubMed ID: 35100917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
    Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C
    Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
    Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
    Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience.
    De Roover A; Detroz B; Detry O; Coimbra C; Polus M; Belaiche J; Meurisse M; Honoré P
    Acta Chir Belg; 2006; 106(3):297-301. PubMed ID: 16910002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.
    Saladino E; Fleres F; Mazzeo C; Pruiti V; Scollica M; Rossitto M; Cucinotta E; Macrì A
    Anticancer Res; 2014 Apr; 34(4):2019-22. PubMed ID: 24692741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.